Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
Pearlstein KA, Wang K, Amdur RJ, Shen CJ, Dagan R, Weiss J, Grilley-Olson JE, Zanation A, Hackman TG, Thorp BD, Blumberg JM, Patel S, Sheets N, Weissler MC, Mendenhall WM, Chera BS.
Pearlstein KA, et al. Among authors: wang k.
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):646-653. doi: 10.1016/j.ijrobp.2018.10.033. Epub 2018 Nov 2.
Int J Radiat Oncol Biol Phys. 2019.
PMID: 30395903
Clinical Trial.